Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $240.29 is 11.18% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 245.35||$ 388.67|
|Low:||$ 235.99||$ 216.12|
ETFs with BIIB as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|4.98%||Invesco Dynamic Biotech & Genome ETF (PBE)||+0.60 (1.16%)|
|4.93%||VanEck Vectors Biotech ETF (BBH)||-0.17 (-0.13%)|
|3.96%||iShares Nasdaq Biotechnology Index Fund (IBB)||-1.08 (-1.00%)|
|2.33%||First Trust Health Care AlphaDEX (FXH)||+2.73 (3.69%)|
|1.77%||iShares Edge MSCI Multifactor USA ETF (LRGF)||+1.45 (4.82%)|
|*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past 100 days.|
Company Description (as filed with the SEC)
Biogen is a global biopharmaceutical company focused on discovering, developing and delivering worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases, including in our core growth areas of multiple sclerosis (MS) and neuroimmunology, Alzheimer's disease (AD) and dementia, movement disorders, including Parkinson's disease, and neuromuscular disorders, including spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS). We are also focused on discovering, developing and delivering worldwide innovative therapies in our emerging growth areas of acute neurology, neurocognitive disorders, pain and ophthalmology. In addition, we are employing innovative technologies to discover potential treatments for rare and genetic disorders, including new ways of treating diseases through gene therapy in our core and emerging growth areas. ... More ...
Nasdaq Official Price
Jun. 25, 2019
Jun. 25, 2019